article thumbnail

Remember the Babies: The Need for Off-Label Pediatric Use of COVID-19 Vaccines

Bill of Health

Centers for Disease Control and Prevention (CDC) is failing parents by preventing off-label use of our existing COVID-19 vaccines in the under-five set. The CDC, through its vaccine provider agreements, prevents physicians and parents from pursuing off-label use of COVID-19 vaccinations in young children.

article thumbnail

Judging in the Pandemic – A Malawian Perspective

Bill of Health

Nevertheless, the onset of the COVID-19 pandemic caused a major panic in the country’s legal system and judiciary. Additionally, the Government declared COVID-19 a “ formidable disease ” under the Public Health Act on April 1, 2020.

COVID-19 307
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reflections on Procedural Barriers to Pediatric COVID Vaccine Access

Bill of Health

When news broke last week that Pfizer-BioNTech was submitting for Emergency Use Authorization (EUA) a two-dose COVID vaccine regimen for children under 5 to the U.S. million children have tested positive for COVID since the pandemic, over 3.5 million children have tested positive for COVID since the pandemic, over 3.5

COVID-19 344
article thumbnail

Hospitals That Ditch Masks Risk Exposure

Bill of Health

NYU’s Langone hospital system decided that — outside of the Emergency Room — patients would generally only be required to mask “if they have fever and cough” (query what percentage of individuals with recent COVID-19 infections did not have this specific combo of symptoms — spoiler: it’s probably high ). As the U.S.

Hospitals 364
article thumbnail

Adding COVID-19 to the informed consent process: A Q&A for health care providers

Health Law Checkup

To minimize their risk should a patient be exposed to COVID-19 while seeking medical care, health care providers should consider supplementing their informed consent process to include information about COVID-19 risks.

article thumbnail

Actionable Insights from the International Collaborative Research Program in Bioscience Innovation & Law

Bill of Health

Emma Kondrup looks at how AI-driven medicine may change how we understand informed consent, and whether existing legislative frameworks provide a good enough safeguard against its risks. Can current EU rules appropriately respond to potential privacy risks and efficacy concerns without unduly hindering innovation?

article thumbnail

DEA role must be clearly defined in controlled substance Rx via telemedicine, expert cautions

Healthcare IT News - Telehealth

Cohen contended that Congress make permanent COVID Public Health Emergency concessions, rather than renewing the concessions biannually. Several advantages to permanent concessions "Making the COVID-19 PHE concessions permanent, rather than renewing them biannually, could provide several advantages," he explained.